Literature DB >> 18097458

Protein therapeutics: a summary and pharmacological classification.

Benjamin Leader1, Quentin J Baca, David E Golan.   

Abstract

Once a rarely used subset of medical treatments, protein therapeutics have increased dramatically in number and frequency of use since the introduction of the first recombinant protein therapeutic--human insulin--25 years ago. Protein therapeutics already have a significant role in almost every field of medicine, but this role is still only in its infancy. This article overviews some of the key characteristics of protein therapeutics, summarizes the more than 130 protein therapeutics used currently and suggests a new classification of these proteins according to their pharmacological action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097458     DOI: 10.1038/nrd2399

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  399 in total

1.  Drug delivery: Relieving PEGylation.

Authors:  Matthew C Parrott; Joseph M DeSimone
Journal:  Nat Chem       Date:  2011-12-15       Impact factor: 24.427

2.  Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers.

Authors:  Beata Chertok; Allan E David; Victor C Yang
Journal:  Biomaterials       Date:  2011-05-31       Impact factor: 12.479

3.  Noninvasive detection of passively targeted poly(ethylene glycol) nanocarriers in tumors.

Authors:  Yashveer Singh; Dayuan Gao; Zichao Gu; Shike Li; Stanley Stein; Patrick J Sinko
Journal:  Mol Pharm       Date:  2011-11-22       Impact factor: 4.939

4.  Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin release.

Authors:  Ruei-Zeng Lin; Alexandra Dreyzin; Kristie Aamodt; Dan Li; Shou-Ching S Jaminet; Andrew C Dudley; Juan M Melero-Martin
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

5.  Maintaining patents protecting biologics or small-molecule drugs.

Authors:  Ganesan Marimuthu; Sangita Kumari; Muthukrishnakumar Kandasamy; Srivatsan Raghunathan; Gayatri Saberwal
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

Review 6.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 7.  Therapeutic proteins.

Authors:  Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2012

Review 8.  Protein-based tumor molecular imaging probes.

Authors:  Xin Lin; Jin Xie; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-03-17       Impact factor: 3.520

9.  Engineered Interactions with Mesoporous Silica Facilitate Intracellular Delivery of Proteins and Gene Editing.

Authors:  Bin Liu; Wardah Ejaz; Shuai Gong; Myrat Kurbanov; Mine Canakci; Francesca Anson; S Thayumanavan
Journal:  Nano Lett       Date:  2020-04-24       Impact factor: 11.189

10.  Magnetic Bead-Immobilized Mammalian Cells Are Effective Targets to Enrich Ligand-Displaying Yeast.

Authors:  Patrick S Lown; Benjamin J Hackel
Journal:  ACS Comb Sci       Date:  2020-04-27       Impact factor: 3.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.